Status:
COMPLETED
Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients
Lead Sponsor:
Dental Innovation Foundation Under Royal Patronage
Collaborating Sponsors:
Thammasat University
Srinakharinwirot University
Conditions:
Cancer of Head and Neck
Cancer
Eligibility:
All Genders
35-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms of dry mouth and impro...
Eligibility Criteria
Inclusion
- cancer patients who receive/ had received radiotherapy and/or chemotherapy and have dry mouth problems
Exclusion
- mucositis more than grade 1
- cannot perform oral intake of gel-based artificial saliva eg. aspirate
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01885065
Start Date
July 1 2012
End Date
December 1 2012
Last Update
June 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahavachiralongkorn cancer hospital
Pathum Thani, Changwat Pathum Thani, Thailand, 12110